New: our own Hairmetry line. Every ingredient explained

Condition

Scalp psoriasis

Scalp psoriasis is an autoimmune skin condition that needs medical treatment, not just a stronger shampoo, and good options exist from topical steroids to biologics.

dandruffitchy scalphair lossshedding

Key takeaways

  • Scalp psoriasis is an autoimmune skin disease, not a shampoo problem. Scalp involvement affects up to 80% of people with plaque psoriasis and is often resistant to topical treatment (Kaur 2025).
  • Look for sharply bordered, thick, silvery-white plaques that extend past the hairline. Dandruff and seborrheic dermatitis flakes are finer, yellowish and less sharply bordered. The two can overlap, and a clinician should tell them apart.
  • First-line treatments are topical: corticosteroids, keratolytics such as salicylic acid, tar and vitamin D analogues. Betamethasone plus calcipotriene is described as the most effective topical combination (Ghafoor 2022). A European consensus offers a grading and treatment algorithm (Ortonne 2009).
  • Biologics work well for severe scalp disease. A 2025 network meta-analysis of 35 randomized trials found every intervention beat placebo, with secukinumab 300 mg and bimekizumab 320 mg ranked highest (Kaur 2025). A 2025 trial tested guselkumab in scalp psoriasis across all skin tones (McMichael 2025).
  • Hair loss can occur but is usually temporary and follows plaque inflammation and scratching. See a dermatologist to rule out other causes.
  • Hair care: gentle scale removal with salicylic acid or coal tar under medical advice, no picking, and soft brushing. A keratolytic hydrating shampoo improved mild to moderate psoriasis in a double-blind vehicle-controlled study (Massiot 2023).

The science

Psoriasis involves an immune loop (T cells and the IL-17 and IL-23 pathways) that speeds up skin-cell turnover. The scalp is hard to treat because hair blocks application and nearby face skin limits irritating options (Ortonne 2009). The efficacy rankings come from the network meta-analysis above, which stressed the lack of head-to-head trials and standardised outcomes.

What it means by hair profile

  • Thick, curly or coily hair: lotions are harder to apply, so foams, solutions and shampoo formats and parting the hair in sections help. The guselkumab trial was designed to include varied skin tones and hair textures (McMichael 2025).
  • Colour-treated or chemically relaxed hair: avoid adding harsh treatments to inflamed skin.
  • Fine hair: greasy ointments weigh hair down, so overnight application and washing out is common practice.

Myths and facts

  • Myth: dandruff shampoo cures psoriasis. Fact: antifungal shampoos help seborrheic overlap, not psoriasis plaques.
  • Myth: it is contagious. Fact: it is not.

Bottom line

See a clinician for a diagnosis if scale is thick or reaches the forehead and ears. Soften scale with a keratolytic, then use a prescribed topical. Moderate to severe disease needs a dermatologist and possibly systemic or biologic therapy. Keep medicated shampoos on the scalp skin and condition the lengths. Discuss with a doctor.

Studies 5

Kaur H et al. Biologic and Non-Biologic Therapies for Scalp Psoriasis: A Network Meta-analysis of Randomized Controlled Trials. Dermatol Pract Concept. 2025

Design
systematic review
People
35
Who
35 randomized trials in scalp psoriasis

Result: Every intervention beat placebo; secukinumab 300 mg and bimekizumab 320 mg ranked highest. Scalp involvement affects up to 80% of people with plaque psoriasis. Authors noted a lack of head-to-head trials.

Read the study ↗

Ghafoor R et al. Treatment of Scalp Psoriasis. J Drugs Dermatol. 2022

Design
review

Result: Topical corticosteroids, keratolytics, tar and vitamin D analogues are first-line; betamethasone plus calcipotriene is described as the most effective topical combination.

Read the study ↗

Ortonne J et al. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol. 2009

Design
guideline

Result: European consensus on grading scalp psoriasis and a treatment algorithm; notes the scalp is hard to treat because hair blocks application.

Read the study ↗

McMichael A et al. Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025

Design
rct
Who
people with moderate to severe scalp psoriasis across all skin tones

Tested: guselkumab

Result: Randomized trial testing guselkumab in scalp psoriasis in people of all skin tones.

Read the study ↗

Massiot P et al. Clinical benefit and tolerance profile of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis. Results from a double-blind, randomized, vehicle-controlled study. 2023

Design
rct
Who
people with mild to moderate scalp psoriasis

Tested: keratolytic and hydrating shampoo versus vehicle

Result: Reported clinical benefit and good tolerance of a keratolytic hydrating shampoo. Industry study.

Read the study ↗